Toshiie Sakata

Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis

Mitsuhiro Yokoyama, Hideki Origasa, Masunori Matsuzaki et al. · The Lancet · 2007 · 2.5K citations

Metabolic Syndrome, Hypercholesterolaemic Patients, Cardiovascular Disease +8

Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: Sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS)

Yasushi Saitō, Mitsuhiro Yokoyama, Hideki Origasa et al. · Atherosclerosis · 2008 · 318 citations

Hypercholesterolemic Patients, Cardiovascular Disease, Health Policy +9

Variations in the FTO gene are associated with severe obesity in the Japanese

Kikuko Hotta, Yoshio Nakata, Tomoaki Matsuo et al. · Journal of Human Genetics · 2008 · 242 citations · Full text

Obesity, Metabolic Syndrome, Biology +11

Relationships between Plasma Fatty Acid Composition and Coronary Artery Disease

Hiroshige Itakura, Mitsuhiro Yokoyama, Masunori Matsuzaki et al. · Journal of Atherosclerosis and Thrombosis · 2011 · 215 citations · Full text

Reduction in the Recurrence of Stroke by Eicosapentaenoic Acid for Hypercholesterolemic Patients

Kortaro Tanaka, Yuichi Ishikawa, Mitsuhiro Yokoyama et al. · Stroke · 2008 · 212 citations